277 related articles for article (PubMed ID: 27176130)
1. CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice.
Wang XQ; Wan HQ; Wei XJ; Zhang Y; Qu P
Mol Med Rep; 2016 Jul; 14(1):49-56. PubMed ID: 27176130
[TBL] [Abstract][Full Text] [Related]
2. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK
Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596
[TBL] [Abstract][Full Text] [Related]
3. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.
Nahon JE; Hoekstra M; Havik SR; Van Santbrink PJ; Dallinga-Thie GM; Kuivenhoven JA; Geerling JJ; Van Eck M
Atherosclerosis; 2018 Jul; 274():120-127. PubMed ID: 29772480
[TBL] [Abstract][Full Text] [Related]
7. Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.
Nogi Y; Nagashima M; Terasaki M; Nohtomi K; Watanabe T; Hirano T
PLoS One; 2012; 7(4):e35683. PubMed ID: 22536426
[TBL] [Abstract][Full Text] [Related]
8. Alteration of volume-regulated chloride channel during macrophage-derived foam cell formation in atherosclerosis.
Hong L; Xie ZZ; Du YH; Tang YB; Tao J; Lv XF; Zhou JG; Guan YY
Atherosclerosis; 2011 May; 216(1):59-66. PubMed ID: 21338988
[TBL] [Abstract][Full Text] [Related]
9. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
10. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.
Terasaki M; Hiromura M; Mori Y; Kohashi K; Nagashima M; Kushima H; Watanabe T; Hirano T
PLoS One; 2015; 10(11):e0143396. PubMed ID: 26606676
[TBL] [Abstract][Full Text] [Related]
12. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
Peng Y; Xu J; Zeng Y; Chen L; Xu XL
Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
[TBL] [Abstract][Full Text] [Related]
13. Macrophage iron retention aggravates atherosclerosis: Evidence for the role of autocrine formation of hepcidin in plaque macrophages.
Xiao L; Luo G; Guo X; Jiang C; Zeng H; Zhou F; Li Y; Yu J; Yao P
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158531. PubMed ID: 31666189
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
[No Abstract] [Full Text] [Related]
15. Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice.
Higashimori M; Tatro JB; Moore KJ; Mendelsohn ME; Galper JB; Beasley D
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):50-7. PubMed ID: 20966403
[TBL] [Abstract][Full Text] [Related]
16. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
[TBL] [Abstract][Full Text] [Related]
17. Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.
Sato K; Shirai R; Yamaguchi M; Yamashita T; Shibata K; Okano T; Mori Y; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891806
[TBL] [Abstract][Full Text] [Related]
18. Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice.
Terasaki M; Nagashima M; Watanabe T; Nohtomi K; Mori Y; Miyazaki A; Hirano T
Metabolism; 2012 Jul; 61(7):974-7. PubMed ID: 22225957
[TBL] [Abstract][Full Text] [Related]
19. Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis.
Wang Y; Dubland JA; Allahverdian S; Asonye E; Sahin B; Jaw JE; Sin DD; Seidman MA; Leeper NJ; Francis GA
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):876-887. PubMed ID: 30786740
[TBL] [Abstract][Full Text] [Related]
20. Effects of FXR in foam-cell formation and atherosclerosis development.
Guo GL; Santamarina-Fojo S; Akiyama TE; Amar MJ; Paigen BJ; Brewer B; Gonzalez FJ
Biochim Biophys Acta; 2006 Dec; 1761(12):1401-9. PubMed ID: 17110163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]